Paul W. Bates
University of Wisconsin-Madison
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Paul W. Bates.
Proceedings of the National Academy of Sciences of the United States of America | 2002
Donald L. Gillian-Daniel; Paul W. Bates; Angie Tebon; Alan D. Attie
Mutations in the low density lipoprotein (LDL) receptor (LDLR) cause hypercholesterolemia because of inefficient LDL clearance from the circulation. In addition, there is a paradoxical oversecretion of the metabolic precursor of LDL, very low density lipoprotein (VLDL). We recently demonstrated that the LDLR mediates pre-secretory degradation of the major VLDL protein, apolipoprotein B (apoB). Kinetic studies suggested that the degradation process is initiated in the secretory pathway. Here, we evaluated the ability of several LDLR variants that are stalled within the secretory pathway to regulate apoB secretion. Both a naturally occurring mutant LDLR and an LDLR consisting of only the ligand-binding domains and a C-terminal endoplasmic reticulum (ER) retention sequence were localized to the ER and not at the cell surface. In the presence of either of the ER-localized LDLRs, apoB secretion was essentially abolished. When the ligand-binding domain of the truncated receptor was mutated the receptor was unable to block apoB secretion, indicating that the inhibition of apoB secretion depends on the ability of the LDLR to bind to its ligand. These findings establish LDLR-mediated pre-secretory apoB degradation as a pathway distinct from reuptake of nascent lipoproteins at the cell surface. The LDLR provides an example of a receptor that modulates export of its ligand from the ER.
Science Signaling | 2004
Paul W. Bates
I kappa B (IκB) was initially identified as a factor that inhibits DNA binding and nuclear translocation of the transcription factor nuclear factor kappa B (NF-κB). Recently, however, IκB family members have demonstrated direct nuclear roles in regulating NF-κB–dependent transcription. Some IκB proteins, including IκBα and IκBβ, can regulate transcription by modulating the concentration of active NF-κB complexes within the nucleus. Others, such as IκBζ and Bcl-3, can directly activate transcription by forming transcriptional complexes at gene promoters. Thus, IκB proteins play important nuclear roles in regulating NF-κB–dependent transcription after stimulation with various extracellular signals.
The Journal of The Association for Persons With Severe Handicaps | 1979
Orv C. Karan; Gail S. Bernstein; John R. Harvey; Paul W. Bates; Adelle Renzaglia; David Rosenthal
This paper presents an extended evaluation model which provides a close and interactive conceptual link between evaluation and treatment processes. For some time there has been a trend in traditional vocational (re)habilitation practices to separate evaluation and treatment as if they were somehow distinct entities. This separateness can no longer continue, particularly now that vocational (re)habilitation programming is being broadened to include those with the most severe handicaps.
Journal of Biological Chemistry | 1995
Jane P. Jensen; Paul W. Bates; Mei Yang; Richard D. Vierstra; Allan M. Weissman
Plant Journal | 1999
Paul W. Bates; Richard D. Vierstra
The British journal of social and clinical psychology | 1978
Paul Wehman; Richard Schutz; Paul W. Bates; Adelle Renzaglia; Orv C. Karan
Immunity | 2011
Yuhong Chen; David T. Yang; Jeffrey D. Kearns; Paul W. Bates; Candace Lynch; Nicholas C. Ladell; Mei Yu; Andrew Podd; Hu Zeng; Tony T. Huang; Renren Wen; Alexander Hoffmann; Demin Wang
Mental Retardation | 1977
Paul W. Bates; Paul Wehman
Education and Treatment of Children | 1982
Paul W. Bates; Adelle Renzaglia
Rehabilitation literature | 1978
Paul Wehman; Paul W. Bates